Medial Prefrontal Area Reductions, Altered Expressions of Cholecystokinin, Parvalbumin, and Activating Transcription Factor 4 in the Corticolimbic System, and Altered Emotional Behavior in a Progressive Rat Model of Type 2 Diabetes

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2021 Sep 10

PMID 34506507

Citations 2

Authors

Ryosuke Ochi

Naoto Fujita

Natsuki Goto

Kaho Takaishi

Takaya Oshima

Son Tien Nguyen

Hisao Nishijo

Susumu Urakawa

Affiliations

Soon will be listed here.

Abstract

Metabolic disorders are associated with a higher risk of psychiatric disorders. We previously reported that 20-week-old Otsuka Long-Evans Tokushima fatty (OLETF) rats, a model of progressive type 2 diabetes, showed increased anxiety-like behavior and regional area reductions and increased cholecystokinin-positive neurons in the corticolimbic system. However, in which stages of diabetes these alterations in OLETF rats occur remains unclear. We aimed to investigate anxiety-like behavior and its possible mechanisms at different stages of type 2 diabetes in OLETF rats. Eight- and 30-week-old OLETF rats were used as diabetic animal models at the prediabetic and progressive stages of type 2 diabetes respectively, and age-matched Long-Evans Tokushima Otsuka rats served as non-diabetic controls. In the open-field test, OLETF rats showed less locomotion in the center zone and longer latency to leave the center zone at 8 and 30 weeks old, respectively. The areas of the medial prefrontal cortex were smaller in the OLETF rats, regardless of age. The densities of cholecystokinin-positive neurons in OLETF rats were higher in the lateral and basolateral amygdala only at 8 weeks old and in the anterior cingulate and infralimbic cortices and hippocampal cornu ammonis area 3 at both ages. The densities of parvalbumin-positive neurons of OLETF rats were lower in the cornu ammonis area 2 at 8 weeks old and in the prelimbic and infralimbic cortices at both ages. No apoptotic cell death was detected in OLETF rats, but the percentage of neurons co-expressing activating transcription factor 4 and cholecystokinin and parvalbumin was higher in OLETF rats at both ages in the anterior cingulate cortex and basolateral amygdala, respectively. These results suggest that altered emotional behavior and related neurological changes in the corticolimbic system are already present in the prediabetic stage of OLETF rats.

Citing Articles

Using lickometry to infer differential contributions of salience network regions during compulsion-like alcohol drinking.

Starski P, Sergio T, Hopf F Addict Neurosci. 2024; 7.

PMID: 38736902 PMC: 11086682. DOI: 10.1016/j.addicn.2023.100102.

Affective and Cognitive Impairments in Rodent Models of Diabetes.

Palazzo E, Marabese I, Boccella S, Belardo C, Pierretti G, Maione S Curr Neuropharmacol. 2024; 22(8):1327-1343.

PMID: 38279738 PMC: 11092917. DOI: 10.2174/1570159X22666240124164804.

References

Hu H, Gan J, Jonas P . Interneurons. Fast-spiking, parvalbumin⁺ GABAergic interneurons: from cellular design to microcircuit function. Science. 2014; 345(6196):1255263. DOI: 10.1126/science.1255263. View

Perez de la Mora M, Hernandez-Gomez A, Arizmendi-Garcia Y, Jacobsen K, Lara-Garcia D, Flores-Gracia C . Role of the amygdaloid cholecystokinin (CCK)/gastrin-2 receptors and terminal networks in the modulation of anxiety in the rat. Effects of CCK-4 and CCK-8S on anxiety-like behaviour and [3H]GABA release. Eur J Neurosci. 2007; 26(12):3614-30. DOI: 10.1111/j.1460-9568.2007.05963.x. View

Clark R, Kochanek P, Watkins S, Chen M, Dixon C, Seidberg N . Caspase-3 mediated neuronal death after traumatic brain injury in rats. J Neurochem. 2000; 74(2):740-53. DOI: 10.1046/j.1471-4159.2000.740740.x. View

Miyasaka K, Kobayashi S, Ohta M, Kanai S, Yoshida Y, Nagata A . Anxiety-related behaviors in cholecystokinin-A, B, and AB receptor gene knockout mice in the plus-maze. Neurosci Lett. 2002; 335(2):115-8. DOI: 10.1016/s0304-3940(02)01176-x. View

Lin Y, Chen T, Hung C, Tai S, Huang S, Chang C . Melatonin protects brain against ischemia/reperfusion injury by attenuating endoplasmic reticulum stress. Int J Mol Med. 2018; 42(1):182-192. PMC: 5979830. DOI: 10.3892/ijmm.2018.3607. View

Ochi R, Fujita N, Goto N, Nguyen S, Le D, Matsushita K . Region-specific brain area reductions and increased cholecystokinin positive neurons in diabetic OLETF rats: implication for anxiety-like behavior. J Physiol Sci. 2020; 70(1):42. PMC: 10717394. DOI: 10.1186/s12576-020-00771-0. View

Li X, Aou S, Hori T, Oomura Y . Spatial memory deficit and emotional abnormality in OLETF rats. Physiol Behav. 2002; 75(1-2):15-23. DOI: 10.1016/s0031-9384(01)00627-8. View

Fujita N, Goto N, Nakamura T, Nino W, Ono T, Nishijo H . Hyperbaric Normoxia Improved Glucose Metabolism and Decreased Inflammation in Obese Diabetic Rat. J Diabetes Res. 2019; 2019:2694215. PMC: 6885850. DOI: 10.1155/2019/2694215. View

Naicker K, Johnson J, Skogen J, Manuel D, Overland S, Sivertsen B . Type 2 Diabetes and Comorbid Symptoms of Depression and Anxiety: Longitudinal Associations With Mortality Risk. Diabetes Care. 2017; 40(3):352-358. DOI: 10.2337/dc16-2018. View

10.

Luo Z, Huang L, Lin S, Yin Y, Jie W, Hu N . Erbin in Amygdala Parvalbumin-Positive Neurons Modulates Anxiety-like Behaviors. Biol Psychiatry. 2020; 87(10):926-936. DOI: 10.1016/j.biopsych.2019.10.021. View

11.

Schroeder M, Weller A . Anxiety-like behavior and locomotion in CCK1 knockout rats as a function of strain, sex and early maternal environment. Behav Brain Res. 2010; 211(2):198-207. DOI: 10.1016/j.bbr.2010.03.038. View

12.

Del Boca C, Lutz P, Le Merrer J, Koebel P, Kieffer B . Cholecystokinin knock-down in the basolateral amygdala has anxiolytic and antidepressant-like effects in mice. Neuroscience. 2012; 218:185-95. PMC: 3532740. DOI: 10.1016/j.neuroscience.2012.05.022. View

13.

Rezayat M, Roohbakhsh A, Zarrindast M, Massoudi R, Djahanguiri B . Cholecystokinin and GABA interaction in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety. Physiol Behav. 2005; 84(5):775-82. DOI: 10.1016/j.physbeh.2005.03.002. View

14.

Sampedro-Piquero P, Castilla-Ortega E, Zancada-Menendez C, Santin L, Begega A . Environmental enrichment as a therapeutic avenue for anxiety in aged Wistar rats: Effect on cat odor exposition and GABAergic interneurons. Neuroscience. 2016; 330:17-25. DOI: 10.1016/j.neuroscience.2016.05.032. View

15.

Kim G, Yoon W, Jeong G . Whole-brain volume alteration and its correlation with anxiety severity in patients with obsessive-compulsive disorder and generalized anxiety disorder. Clin Imaging. 2018; 50:164-170. DOI: 10.1016/j.clinimag.2018.03.008. View

16.

Smith K, Beland M, Clyde M, Gariepy G, Page V, Badawi G . Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res. 2013; 74(2):89-99. DOI: 10.1016/j.jpsychores.2012.11.013. View

17.

Whissell P, Cajanding J, Fogel N, Kim J . Comparative density of CCK- and PV-GABA cells within the cortex and hippocampus. Front Neuroanat. 2015; 9:124. PMC: 4585045. DOI: 10.3389/fnana.2015.00124. View

18.

Krukowski K, Nolan A, Frias E, Boone M, Ureta G, Grue K . Small molecule cognitive enhancer reverses age-related memory decline in mice. Elife. 2020; 9. PMC: 7721440. DOI: 10.7554/eLife.62048. View

19.

Abu Fanne R, Nassar T, Heyman S, Hijazi N, Higazi A . Insulin and glucagon share the same mechanism of neuroprotection in diabetic rats: role of glutamate. Am J Physiol Regul Integr Comp Physiol. 2011; 301(3):R668-73. PMC: 3174750. DOI: 10.1152/ajpregu.00058.2011. View

20.

Yang L, Dong Y, Wu C, Li Y, Guo Y, Yang B . Photobiomodulation preconditioning prevents cognitive impairment in a neonatal rat model of hypoxia-ischemia. J Biophotonics. 2019; 12(6):e201800359. PMC: 6546525. DOI: 10.1002/jbio.201800359. View